| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +87.50% | +4.48% | +0.39% | +4.09% | +6.63% | — |
| 14d | 8 | +50.00% | -4.34% | -1.92% | -2.42% | -3.29% | — |
| 30d | 8 | +37.50% | -2.42% | -1.85% | -0.56% | +0.94% | — |
| 60d | 8 | +37.50% | -14.92% | -2.81% | -12.10% | -12.72% | — |
| 90d | 8 | +50.00% | -10.55% | -1.39% | -9.16% | -6.59% | — |
| 180d | 8(1 pending) | +42.86% | -6.87% | -2.28% | -4.59% | +6.85% | — |
| 1y | 8(1 pending) | +57.14% | +42.62% | +1.32% | +41.30% | +72.24% | — |
| 2y | 8(3 pending) | +80.00% | +44.16% | +4.88% | +39.27% | +69.29% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AXSM AXSOME THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 33,000 | $240.09 | $7.92M | 42,867 | Jun 9, 2026 | Jun 9, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | SALE Chief Financial Officer | 33,000 | — | — | 72,000 | Jun 9, 2026 | Jun 9, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 33,000 | $3.50 | $115.5K | 75,867 | Jun 9, 2026 | Jun 9, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 8,188 | — | — | 8,188 | Apr 21, 2026 | Apr 23, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,570 | — | — | 18,570 | Feb 26, 2026 | Feb 27, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 12,000 | $3.50 | $42.0K | 54,588 | Jan 22, 2026 | Jan 23, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $187.92 | $2.26M | 42,588 | Jan 22, 2026 | Jan 23, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,000 | — | — | 105,000 | Jan 22, 2026 | Jan 23, 2026 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,423 | — | — | 9,423 | Feb 24, 2025 | Feb 25, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,423 | — | — | 9,423 | Feb 21, 2025 | Feb 25, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,516 | — | — | 9,516 | Feb 21, 2025 | Feb 25, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,000 | $131.07 | $393.2K | 42,187 | Feb 14, 2025 | Feb 14, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 3,000 | $3.50 | $10.5K | 45,187 | Feb 14, 2025 | Feb 14, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,000 | $3.50 | $10.5K | 0 | Feb 14, 2025 | Feb 14, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 12,000 | $129.86 | $1.56M | 42,187 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,000 | $3.50 | $42.0K | 0 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 12,000 | $3.50 | $42.0K | 54,187 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,774 | — | — | 15,774 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,722 | — | — | 28,722 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,554 | — | — | 20,554 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,246 | — | — | 36,246 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 41,176 | — | — | 41,176 | Mar 4, 2022 | Mar 8, 2022 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 77,872 | — | — | 77,872 | Mar 4, 2022 | Mar 8, 2022 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE CHIEF FINANCIAL OFFICER | 142 | $35.20 | $5.0K | 142 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE CHIEF FINANCIAL OFFICER | 141 | $35.43 | $5.0K | 201 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE CHIEF FINANCIAL OFFICER | 145 | $34.30 | $5.0K | 145 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE CHIEF FINANCIAL OFFICER | 527 | $35.50 | $18.7K | 41,789 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,086 | — | — | 36,086 | Nov 12, 2021 | Nov 15, 2021 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,208 | — | — | 19,208 | Mar 5, 2021 | Mar 9, 2021 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,086 | — | — | 36,086 | Mar 5, 2021 | Mar 9, 2021 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 777 | $76.64 | $59.5K | 41,217 | Jun 29, 2020 | Jun 30, 2020 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 48,237 | — | — | 48,237 | Mar 17, 2020 | Dec 23, 2020 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,767 | — | — | 14,767 | Mar 17, 2020 | Dec 23, 2020 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,880 | — | — | 60,880 | Mar 17, 2020 | Mar 19, 2020 ↗ | View → |
| AXSM AXSOME THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,645 | — | — | 18,645 | Mar 17, 2020 | Mar 19, 2020 ↗ | View → |